{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:23:48Z","timestamp":1792113828371,"version":"4.4.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-022-02447-x","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T22:03:05Z","timestamp":1668636185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development, Quality by Design-Based Optimization, and Stability Assessment of Oral Liquid Formulations Containing Baclofen for Hospital Use"],"prefix":"10.1208","volume":"23","author":[{"given":"Elisa","family":"de Saldanha Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie Ribeiro","family":"Wingert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caren","family":"Gobetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele Bordignon","family":"Primieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcio Vin\u00edcius","family":"Ayres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Helena Oliveira","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Maria","family":"Volpato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Steppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"issue":"4","key":"2447_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11096-006-9081-z","volume":"29","author":"M Dell\u2019aera","year":"2004","unstructured":"Dell\u2019aera M, Garbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, et al. Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci. 2004;29(4):361\u20137.","journal-title":"Pharm World Sci."},{"key":"2447_CR2","first-page":"218","volume":"136","author":"ER Di Paolo","year":"2006","unstructured":"Di Paolo ER, Stoetter H, Cotting J, Frey P, Gehri M, Beck-Popovic M, et al. Unlicensed and off label drug use in a Swiss paediatric university hospital. Swiss Med Wkly. 2006;136:218\u201322.","journal-title":"Swiss Med Wkly"},{"issue":"12","key":"2447_CR3","first-page":"1","volume":"40","author":"P Langerov\u00e1","year":"2014","unstructured":"Langerov\u00e1 P, Vrtal J, Urb\u00e1nek K. Incidence of unlicensed and off-label prescription in children. Ital J Pediatr. 2014;40(12):1\u20136.","journal-title":"Ital J Pediatr"},{"issue":"2","key":"2447_CR4","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00228-011-1072-x","volume":"67","author":"J Lass","year":"2011","unstructured":"Lass J, K\u00e4\u00e4r R, J\u00f5gi K, Varendi H, Metsvaht T, Lutsar I. Drug utilisation pattern and off-label use of medicines in Estonian neonatal units. Eur J Clin Pharmacol. 2011;67(2):1263\u201371.","journal-title":"Eur J Clin Pharmacol"},{"key":"2447_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s00431-005-1698-8","volume":"164","author":"C Pandolfini","year":"2005","unstructured":"Pandolfini C, Bonati E. A literature review on off-label drug use in children. Eur J Pediatr. 2005;164:552\u20138.","journal-title":"Eur J Pediatr"},{"key":"2447_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijpharm.2005.05.006","volume":"300","author":"JF Standing","year":"2005","unstructured":"Standing JF, Tuleu C. Paediatric formulations - getting to the heart of the problem. Int J of Pharm. 2005;300:56\u20136.","journal-title":"Int J of Pharm"},{"issue":"5","key":"2447_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2223\/JPED.1069","volume":"79","author":"PRA Carvalho","year":"2003","unstructured":"Carvalho PRA, Carvalho CG, Alievi PT, Martinbiancho J, Trotta EA. Prescription of drugs not appropriate for children in a pediatric intensive care unit. J Pediatr. 2003;79(5):397\u2013402.","journal-title":"J Pediatr"},{"issue":"1","key":"2447_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1590\/S1984-82502009000100007","volume":"45","author":"PQ Costa","year":"2009","unstructured":"Costa PQ, Lima JES, Coelho HLL. Prescri\u00e7\u00e3o e preparo de medicamentos sem formula\u00e7\u00e3o adequada para crian\u00e7as: um estudo de base hospitalar. Braz J Pharm Sci. 2009;45(1):57\u201366.","journal-title":"Braz J Pharm Sci"},{"issue":"1","key":"2447_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0104-4230(12)70159-8","volume":"58","author":"LA Ferreira","year":"2012","unstructured":"Ferreira LA, Ibiapina CC, Machado MGP, Fagundes EDT. High prevalence of off-label and unlicensed drug prescribing in a Brazilian intensive care unit. Rev Assoc Med Bras. 2012;58(1):82\u20137.","journal-title":"Rev Assoc Med Bras"},{"key":"2447_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11096-008-9268-6","volume":"31","author":"I Heineck","year":"2009","unstructured":"Heineck I, Bueno D, Heydrich J. Study on the use of drugs in patients with enteral feeding tubes. Pharm World Sci. 2009;31:145\u20138.","journal-title":"Pharm World Sci"},{"key":"2447_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00228-014-1768-9","volume":"71","author":"J Magalh\u00e3es","year":"2015","unstructured":"Magalh\u00e3es J, Rodrigues AT, Roque F, Figueiras A, Falc\u00e3o A, Herdeiro MT. Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review. Eur J Clin Pharmacol. 2015;71:1\u201313.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"2447_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.18433\/J38887","volume":"16","author":"A Haywood","year":"2013","unstructured":"Haywood A, Glass BD. Liquid dosage forms extemporaneously prepared from commercially available products - considering new evidence on stability. J Pharm Pharm Sci. 2013;16(3):441\u201355.","journal-title":"J Pharm Pharm Sci"},{"issue":"5","key":"2447_CR13","first-page":"996","volume":"30","author":"L Santos","year":"2011","unstructured":"Santos L, Heineck L. Extemporaneous oral preparations. An alternative for hospitalized children. Lat Am J Pharm. 2011;30(5):996\u20131000.","journal-title":"Lat Am J Pharm"},{"key":"2447_CR14","unstructured":"Brazilian Health Regulatory Agency - ANVISA. Collegiate Board - RDC n\u00b0 67 of 8 October 2007. Bras\u00edlia: Federal Official Gazette; 2007."},{"key":"2447_CR15","unstructured":"Barker SA. Suspens\u00f5es. In: Aulton ME, Taylor KMG. Delineamento de formas farmac\u00eauticas. 4th ed. Porto Alegre: Artmed; 2016."},{"key":"2447_CR16","unstructured":"Murdan S. Solu\u00e7\u00f5es. In: Aulton ME, Taylor KMG. Delineamento de formas farmac\u00eauticas. 4th ed. Porto Alegre: Artmed; 2016."},{"issue":"2","key":"2447_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1515\/pthp-2018-0008","volume":"3","author":"C Bruns","year":"2018","unstructured":"Bruns C, Ober M. Development and preparation of oral suspensions for paediatric patients \u2013 a challenge for pharmacists. Pharm Technol Hosp Pharm. 2018;3(2):113\u20139.","journal-title":"Pharm Technol Hosp Pharm"},{"key":"2447_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.09.015","volume":"365","author":"A Cram","year":"2009","unstructured":"Cram A, Breitkreutz J, Desset-Br\u00e8thes S, Nunn T, Tuleu C. Challenges of developing palatable oral paediatric formulations. Int J Pharm. 2009;365:1\u20133.","journal-title":"Int J Pharm"},{"key":"2447_CR19","unstructured":"Gaisford S. Pr\u00e9-formula\u00e7\u00e3o farmac\u00eautica. In: Aulton ME, Taylor KMG. Delineamento de formas farmac\u00eauticas. 4th ed. Porto Alegre: Artmed; 2016."},{"key":"2447_CR20","unstructured":"Gibson M. Pharmaceutical preformulation and formulation: a practical guide from candidate drug selection to commercial dosage form. 2nd ed. New York: Informa Healthcare; 2009."},{"key":"2447_CR21","unstructured":"ICH. Q8(R2). Pharmaceutical development. 2009."},{"key":"2447_CR22","doi-asserted-by":"crossref","unstructured":"Fukuda IM, Pinto CFF, Moreira CS, Saviano AM, Louren\u00e7o FR. Design of experiments (DoE) applied to pharmaceutical and analytical quality by design (QbD). Braz J Pharm Sci. 2018;54(Special).","DOI":"10.1590\/s2175-97902018000001006"},{"key":"2447_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejpb.2019.12.007","volume":"147","author":"HB Grangeia","year":"2020","unstructured":"Grangeia HB, Silva C, Sim\u00f5es SP, Reis MS. Quality by design in pharmaceutical manufacturing: a systematic review of current status, challenges and future perspectives. Eur J Pharm Biopharm. 2020;147:19\u201337.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"2447_CR24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s11095-007-9511-1","volume":"25","author":"LX Yu","year":"2008","unstructured":"Yu LX. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res. 2008;25(4):781\u201391.","journal-title":"Pharm Res"},{"issue":"4","key":"2447_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1208\/s12248-014-9598-3","volume":"16","author":"LX Yu","year":"2014","unstructured":"Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, Woodcock J. Understanding pharmaceutical quality by design. AAPS J. 2014;16(4):771\u201383.","journal-title":"AAPS J"},{"key":"2447_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-31187-1","volume-title":"Optimization methods: from theory to design scientific and technological aspects","author":"M Cavazzuti","year":"2013","unstructured":"Cavazzuti M. Optimization methods: from theory to design scientific and technological aspects. Verlag Berlin Heidelberg: Springer; 2013."},{"issue":"1","key":"2447_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.14450\/2318-9312.v29.e1.a2017.pp5-12","volume":"29","author":"MP Bezerra","year":"2017","unstructured":"Bezerra MP, Rodrigues LNC. Quality by design (QbD) as a tool for optimization of pharmaceutical processes. Infarma-Ci\u00eancias Farmac\u00eauticas. 2017;29(1):5\u201312.","journal-title":"Infarma-Ci\u00eancias Farmac\u00eauticas"},{"key":"2447_CR28","doi-asserted-by":"crossref","unstructured":"Destro F, Barolo M. A review on the modernization of pharmaceutical development and manufacturing \u2013 trends, perspectives, and the role of mathematical modeling. 2022;620:1\u201326.","DOI":"10.1016\/j.ijpharm.2022.121715"},{"issue":"3","key":"2447_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/pharmaceutics12030287","volume":"12","author":"S Namjoshi","year":"2020","unstructured":"Namjoshi S, Dabbaghi M, Roberts MS, Gricce JE, Mohammed Y. Quality by design: development of the quality target product profile (QTPP) for semisolid topical products. Pharmaceutics. 2020;12(3):287.","journal-title":"Pharmaceutics"},{"key":"2447_CR30","unstructured":"Brazilian Health Regulatory Agency - ANVISA. Collegiate Board - RDC n\u00b0 318 of 6 November 2019. Bras\u00edlia: Federal Official Gazette; 2019."},{"key":"2447_CR31","unstructured":"O'donnell PB, Bokser AD. Stability of pharmaceutical products. In: Troy DB; Beringer P. Remington: the science and practice of pharmacy, 22nd ed. Philadelphia: The University of the Sciences; 2013."},{"key":"2447_CR32","unstructured":"Drugbank. Drug and drug target database. Baclofen. 2022. https:\/\/www.drugbank.ca\/drugs\/DB00181. Accessed 05 June 2022."},{"key":"2447_CR33","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1021\/acschemneuro.0c00254","volume":"11","author":"CN Kent","year":"2020","unstructured":"Kent CN, Park C, Lindsley CW. Classics in chemical neuroscience: baclofen. ACS Chem Neurosci. 2020;11:1740\u201355.","journal-title":"ACS Chem Neurosci"},{"key":"2447_CR34","unstructured":"Pubchem. Compound summary. Baclofen. 2022. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/2284#section=Top. Accessed 05 June 2022."},{"key":"2447_CR35","unstructured":"British Pharmacopoeia. British Pharmacopoeia Commission Office. London: The Stationery Office; 2014."},{"key":"2447_CR36","unstructured":"The Japanese Pharmacopoeia. 17th ed. Tokyo: Society of Japanese Pharmacopoeia; 2016."},{"key":"2447_CR37","unstructured":"USP 45. The United States Pharmacopeia. 45th ed. Rockville: United States Pharmacopeia Convention; 2022."},{"issue":"10","key":"2447_CR38","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s11094-015-1172-5","volume":"48","author":"OA Dukova","year":"2015","unstructured":"Dukova OA, Kraasnov EA, Efremov AA. Development of an HPLC method for determining baclofen. Pharm Chem J. 2015;48(10):689\u201391.","journal-title":"Pharm Chem J"},{"issue":"4","key":"2447_CR39","first-page":"255","volume":"21","author":"AO Ferreira","year":"2017","unstructured":"Ferreira AO, Polonini H, Silva SL, Aglio NCB, Abreu J, Brand\u00e3o MAF. Stability of acetazolamide, baclofen, dipyridamole, mebevarine hydrochloride, propylthiouracil, quinidine sulfate, and topiramate oral suspensions in SyrSpend SF PH4. Int J Pharm Compd. 2017;21(4):255\u201362.","journal-title":"Int J Pharm Compd"},{"issue":"2","key":"2447_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.22456\/2527-2616.87929","volume":"2","author":"J Santos","year":"2018","unstructured":"Santos J, Rosa P, Adams AIH. Validation of a simple reversed phase-HPLC method for determination of baclofen in tablets. Drug Anal Res. 2018;2(2):37\u201343.","journal-title":"Drug Anal Res"},{"key":"2447_CR41","unstructured":"Lioresal\u00ae Liquid [package insert on the internet]. London: Novartis Pharmaceuticals UK Ltd, 2021. Available from:\u00a0https:\/\/www.medicines.org.uk\/emc\/files\/pil.1280.pdf. Accessed 4 July 2022."},{"key":"2447_CR42","unstructured":"Ozobax\u00ae Oral Solution [package insert on the internet]. Athens: Metacel Pharmaceuticals, LLC, 2020. Available from:\u00a0https:\/\/ozobax.com\/wp-content\/uploads\/2020\/08\/P-010165-V1.pdf. Accessed 4 July 2022."},{"key":"2447_CR43","unstructured":"Lioresal\u00ae Tablets 10 mg [package insert on the internet]. S\u00e3o Paulo: Novartis Bioci\u00eancias S.A., 2021. Available from:\u00a0https:\/\/portal.novartis.com.br\/medicamentos\/wp-content\/uploads\/2021\/10\/Bula-LIORESAL-Comprimido-Paciente.pdf. Accessed 4 July 2022."},{"issue":"3","key":"2447_CR44","first-page":"12","volume":"5","author":"RN Marinho","year":"2014","unstructured":"Marinho RN, Cabral CHK. Study adaptations of pharmaceutical formulations in a university children\u2019s hospital. RBFHSS. 2014;5(3):12\u20137.","journal-title":"RBFHSS"},{"issue":"18","key":"2447_CR45","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1093\/ajhp\/53.18.2179","volume":"53","author":"LV Allen","year":"1996","unstructured":"Allen LV, Erickson MA. Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids. Am J Health-Syst Pharm. 1996;53(18):2179\u201384.","journal-title":"Am J Health-Syst Pharm"},{"issue":"11","key":"2447_CR46","first-page":"2353","volume":"50","author":"CE Johnson","year":"1993","unstructured":"Johnson CE, Hart SM. Stability of an extemporaneously compounded baclofen oral liquid. Am J Hosp Pharm. 1993;50(11):2353\u20135.","journal-title":"Am J Hosp Pharm"},{"issue":"6","key":"2447_CR47","first-page":"516","volume":"22","author":"H Polonini","year":"2018","unstructured":"Polonini H, Silva SL, Brand\u00e3o MAF, Bauters T, De Moerloose B, Ferreira AO. Compatibility of baclofen, carvedilol, hydrochlorothiazide, mercaptopurine, methadone hydrochloride, oseltamivir phosphate, phenobarbital, propranolol hydrochloride, pyrazinamide, sotalol hydrochloride, spironolactone, tacrolimus monohydrate, ursodeoxycholic acid, and vancomycin hydrochloride oral suspensions compounded with SyrSpend SF pH4. Int Pharm Compd. 2018;22(6):516\u201326.","journal-title":"Int Pharm Compd"},{"key":"2447_CR48","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/jppr.1750","volume":"51","author":"TJ Purohit","year":"2021","unstructured":"Purohit TJ, Thakur SS, Carruth J, Dean F, Kim D, Lee S, et al. Formulation and stability evaluation of an extemporaneuously prepared baclofen suspension (1 mg\/mL). J Pharm Pract Res. 2021;51:314\u201320.","journal-title":"J Pharm Pract Res"},{"key":"2447_CR49","volume-title":"Prepara\u00e7\u00f5es Orais L\u00edquidas: Formul\u00e1rio, procedimento de preparo, flavoriza\u00e7\u00e3o, estabilidade e conserva\u00e7\u00e3o","author":"AO Ferreira","year":"2005","unstructured":"Ferreira AO, Souza GF. Prepara\u00e7\u00f5es Orais L\u00edquidas: Formul\u00e1rio, procedimento de preparo, flavoriza\u00e7\u00e3o, estabilidade e conserva\u00e7\u00e3o. 1st ed. S\u00e3o Paulo: Pharmabooks; 2005.","edition":"1"},{"key":"2447_CR50","volume-title":"Pharmaceutics: dosage form and design","author":"D Jones","year":"2008","unstructured":"Jones D. Pharmaceutics: dosage form and design. London: Pharmaceutical Press; 2008."},{"key":"2447_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/0470087951","volume-title":"HPLC for pharmaceutical scientists","author":"Y Kazakevich","year":"2007","unstructured":"Kazakevich Y, Lobrutto R. HPLC for pharmaceutical scientists. New Jersey: John Wiley & Sons; 2007."},{"issue":"3","key":"2447_CR52","first-page":"69","volume":"1","author":"AJS Neto","year":"2009","unstructured":"Neto AJS. Problemas com o formato dos picos em cromatografia l\u00edquida. Scientia Chromatographica. 2009;1(3):69\u201377.","journal-title":"Scientia Chromatographica"},{"key":"2447_CR53","unstructured":"ICH. Q2B(R1). Validation of analytical procedures: text and methodology. 2005"},{"key":"2447_CR54","unstructured":"Brazilian Pharmacopoea. 6th ed. Bras\u00edlia: Anvisa; 2019."},{"key":"2447_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1590\/S0102-695X2003000300017","volume":"13","author":"NC Lubi","year":"2003","unstructured":"Lubi NC, Sato MEO, Gaensly F. Desenvolvimento de forma farmac\u00eautica l\u00edquida de uso oral, isenta de subst\u00e2ncias glicog\u00eanicas, com extrato fluido de Mikania glomerata Sprengel - Asteraceae (guaco). Rev Bras Farmacogn. 2003;13:43\u20136.","journal-title":"Rev Bras Farmacogn"},{"key":"2447_CR56","volume-title":"Handbook of pharmaceutical excipients","author":"RC Rowe","year":"2009","unstructured":"Rowe RC, Scheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009.","edition":"6"},{"key":"2447_CR57","unstructured":"Lachman L, Lieberman HA, Kanig JL. Teoria e pr\u00e1tica na ind\u00fastria farmac\u00eautica. 2nd ed. Lisboa: Calouste Gulben Kian; 2010. vol.2."},{"key":"2447_CR58","unstructured":"Collins CH, Braga GL, Bonato PS. Fundamentos de Cromatografia, 1st ed. Campinas: Unicamp; 2006."},{"issue":"7","key":"2447_CR59","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/tmi.12508","volume":"20","author":"MC Garc\u00eda","year":"2015","unstructured":"Garc\u00eda MC, Manzo RH, Jimenez-Kairuz AF. Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in pediatric patients. Trop Med Int Health. 2015;20(7):864\u201370.","journal-title":"Trop Med Int Health"},{"key":"2447_CR60","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.powtec.2010.01.010","volume":"199","author":"SLA Hennart","year":"2010","unstructured":"Hennart SLA, Wildeboer WJ, Van Hee P, Meesters GMH. Stability of particle suspensions after fine grinding. Powder Technol. 2010;199:226\u201331.","journal-title":"Powder Technol"},{"issue":"12","key":"2447_CR61","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1080\/02652030050207729","volume":"17","author":"C Ferrand","year":"2000","unstructured":"Ferrand C, Marc F, Fritsch P, Saint de Blanquat G. Influence of various parameters on the browning of potassium sorbate in the presence of amines. Food Addit Contam. 2000;17(12):947\u201356.","journal-title":"Food Addit Contam"},{"key":"2447_CR62","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1365-2621.1998.00136.x","volume":"33","author":"JH Han","year":"1998","unstructured":"Han JH, Floros JD. Modelling the change in colour of potassium sorbate powder during heating. Int J Food Sci Technol. 1998;33:199\u2013203.","journal-title":"Int J Food Sci Technol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-022-02447-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T17:22:29Z","timestamp":1669656149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-022-02447-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":62,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["2447"],"URL":"https:\/\/doi.org\/10.1208\/s12249-022-02447-x","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"4 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"301"}}